Anti-CALCRL/CGRPR Antibody (Erenumab)
Catalog No.
F1110
Anti-CALCRL/CGRPR Antibody (Erenumab)
Featured Products
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab is indicated for the prevention of episodic migraine headaches.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.2 kDa
Dry ice
1582205-90-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Aimovig, AMG 334
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q16602
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CGRPR VLP Protein at 16 ug/mL can bind Anti-CALCRL/CGRPR Antibody (Erenumab)
CALCRL / CGRPR
Please avoid freeze-thaw cycles.